Bellicum pharmaceuticals inc reports quarterly loss per share of $0.68

Bellicum pharmaceuticals reports third quarter 2019 financial results and provides operational update.bellicum reported cash, restricted cash and investments totaling $106.9 million as of september 30, 2019.qtrly loss per share $0.68.q3 earnings per share view $-0.53 -- refinitiv ibes data.

BLCM Ratings Summary

BLCM Quant Ranking